Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    CAN-004
Show Display Options
Rank Status Study
1 Terminated Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy or Second-Line Treatment
Condition: Epithelial Ovarian Cancer
Interventions: Biological: Placebo;   Biological: Cvac

Study has passed its completion date and status has not been verified in more than two years.